EIF2AK3 and pulmonary fibrosis: In vivo, however, we found that PERK inhibition with GSK2606414 failed to prevent pulmonary fibrosis after bleomycin, while IRE1α inhibition with KIRA7 or KIRA8 both prevented and reversed fibrosis.